These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16817686)

  • 1. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
    Liu Y; Ng K; Lillehei KO
    Neurosurg Focus; 2000 Dec; 9(6):e3. PubMed ID: 16817686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
    Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
    J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.
    Smilowitz HM; Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Youngs K; Tu W; Coderre JA
    J Neurooncol; 2000; 46(3):193-203. PubMed ID: 10902851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
    Xiao ZY; Chen XJ; Yang Y; Xu RX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
    DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
    J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
    Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM
    Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
    Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
    Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration.
    Driessens G; Gordower L; Nuttin L; Stordeur P; Blocklet D; Egrise D; Velu T; Bruyns C
    Cancer Immunol Immunother; 2008 Dec; 57(12):1745-56. PubMed ID: 18369621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
    Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
    J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
    Manome Y; Wen PY; Hershowitz A; Tanaka T; Rollins BJ; Kufe DW; Fine HA
    Cancer Immunol Immunother; 1995 Oct; 41(4):227-35. PubMed ID: 7489565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
    Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
    Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
    Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
    Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
    J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.
    Clavreul A; Delhaye M; Jadaud E; Menei P
    J Neurooncol; 2006 Aug; 79(1):9-17. PubMed ID: 16575532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    Zhu X; Lu C; Xiao B; Qiao J; Sun Y
    J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma.
    Kruse CA; Mitchell DH; Kleinschmidt-DeMasters BK; Bellgrau D; Eule JM; Parra JR; Kong Q; Lillehei KO
    J Neurooncol; 1993 Feb; 15(2):97-112. PubMed ID: 8509824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.